How to develop new systemic treatments in ultra-rare cancers with high unmet needs?: The case of alveolar soft-part sarcoma
Developing new drugs or generating evidence for existing drugs in new indications for ultra-rare cancers is complex and carries a high-risk of failure. This gets even harder in ultra-rare tumours, which have an annual incidence of 1 per 1,000,000 population or less. Here, we illustrate the problem o...
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
May 2024
|
| In: |
European journal of cancer
Year: 2024, Jahrgang: 202, Pages: [1]-5 |
| ISSN: | 1879-0852 |
| DOI: | 10.1016/j.ejca.2024.114003 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.ejca.2024.114003 Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S095980492400159X 
|
| Verfasserangaben: | Silvia Stacchiotti, Gauthier Bouche, Ralf Herold, Pan Pantziarka, Kathrin Schuster, Roger Wilson, Francesco Pignatti, Bernd Kasper |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1902322231 | ||
| 003 | DE-627 | ||
| 005 | 20241205171427.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240911s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ejca.2024.114003 |2 doi | |
| 035 | |a (DE-627)1902322231 | ||
| 035 | |a (DE-599)KXP1902322231 | ||
| 035 | |a (OCoLC)1475311273 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Stacchiotti, Silvia |e VerfasserIn |0 (DE-588)1164087444 |0 (DE-627)1028474644 |0 (DE-576)508363071 |4 aut | |
| 245 | 1 | 0 | |a How to develop new systemic treatments in ultra-rare cancers with high unmet needs? |b The case of alveolar soft-part sarcoma |c Silvia Stacchiotti, Gauthier Bouche, Ralf Herold, Pan Pantziarka, Kathrin Schuster, Roger Wilson, Francesco Pignatti, Bernd Kasper |
| 264 | 1 | |c May 2024 | |
| 300 | |a 5 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 11.09.2024 | ||
| 520 | |a Developing new drugs or generating evidence for existing drugs in new indications for ultra-rare cancers is complex and carries a high-risk of failure. This gets even harder in ultra-rare tumours, which have an annual incidence of 1 per 1,000,000 population or less. Here, we illustrate the problem of adequate evidence generation in ultra-rare tumours, using Alveolar Soft-Part Sarcomas (ASPS) - an ultra-rare sarcoma newly diagnosed in approximately 60 persons a year in the European Union - as an exemplar case showing challenges in development despite being potentially relevant for classes of agents. We discuss some possible approaches for addressing such challenges, especially focussing on constructive collaboration between academic groups, patients and advocates, drug manufacturers, and regulators to optimise drug development in ultra-rare cancers. This article, written by various European stakeholders, proposes a way forward to ultimately get better options for patients with ultra-rare cancers. | ||
| 650 | 4 | |a Clinical trials | |
| 650 | 4 | |a Drug development | |
| 650 | 4 | |a Sarcomas | |
| 650 | 4 | |a Ultra-rare cancers | |
| 700 | 1 | |a Bouche, Gauthier |e VerfasserIn |4 aut | |
| 700 | 1 | |a Herold, Ralf |e VerfasserIn |4 aut | |
| 700 | 1 | |a Pantziarka, Pan |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schuster, Kathrin |e VerfasserIn |4 aut | |
| 700 | 1 | |a Wilson, Roger |e VerfasserIn |4 aut | |
| 700 | 1 | |a Pignatti, Francesco |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kasper, Bernd |d 1974- |e VerfasserIn |0 (DE-588)12274764X |0 (DE-627)082130736 |0 (DE-576)29340447X |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t European journal of cancer |d Amsterdam [u.a.] : Elsevier, 1992 |g 202(2024) vom: Mai, Artikel-ID 114003, Seite [1]-5 |w (DE-627)266883400 |w (DE-600)1468190-0 |w (DE-576)090954173 |x 1879-0852 |7 nnas |a How to develop new systemic treatments in ultra-rare cancers with high unmet needs? The case of alveolar soft-part sarcoma |
| 773 | 1 | 8 | |g volume:202 |g year:2024 |g month:05 |g elocationid:114003 |g pages:[1]-5 |g extent:5 |a How to develop new systemic treatments in ultra-rare cancers with high unmet needs? The case of alveolar soft-part sarcoma |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.ejca.2024.114003 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.sciencedirect.com/science/article/pii/S095980492400159X |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20240911 | ||
| 993 | |a Article | ||
| 994 | |a 2024 | ||
| 998 | |g 12274764X |a Kasper, Bernd |m 12274764X:Kasper, Bernd |d 60000 |d 61200 |e 60000PK12274764X |e 61200PK12274764X |k 0/60000/ |k 1/60000/61200/ |p 8 |y j | ||
| 999 | |a KXP-PPN1902322231 |e 4578723712 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"note":["Gesehen am 11.09.2024"],"relHost":[{"title":[{"title":"European journal of cancer","title_sort":"European journal of cancer"}],"part":{"volume":"202","year":"2024","text":"202(2024) vom: Mai, Artikel-ID 114003, Seite [1]-5","pages":"[1]-5","extent":"5"},"language":["eng"],"pubHistory":["28.1992 -"],"recId":"266883400","origin":[{"publisherPlace":"Amsterdam [u.a.] ; [Erscheinungsort nicht ermittelbar]","dateIssuedKey":"1992","publisher":"Elsevier ; Pergamon Press","dateIssuedDisp":"1992-"}],"titleAlt":[{"title":"EJC online"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"id":{"issn":["1879-0852"],"zdb":["1468190-0"],"eki":["266883400"]},"disp":"How to develop new systemic treatments in ultra-rare cancers with high unmet needs? The case of alveolar soft-part sarcomaEuropean journal of cancer","note":["Gesehen am 21.03.24","Ungezählte Beil.: Supplement"],"corporate":[{"display":"European Organization for Research on Treatment of Cancer","role":"isb"},{"display":"European Association for Cancer Research","role":"isb"},{"role":"isb","display":"European School of Oncology"}]}],"physDesc":[{"extent":"5 S."}],"id":{"doi":["10.1016/j.ejca.2024.114003"],"eki":["1902322231"]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"recId":"1902322231","origin":[{"dateIssuedKey":"2024","dateIssuedDisp":"May 2024"}],"person":[{"role":"aut","given":"Silvia","display":"Stacchiotti, Silvia","family":"Stacchiotti"},{"family":"Bouche","display":"Bouche, Gauthier","role":"aut","given":"Gauthier"},{"family":"Herold","given":"Ralf","role":"aut","display":"Herold, Ralf"},{"display":"Pantziarka, Pan","given":"Pan","role":"aut","family":"Pantziarka"},{"family":"Schuster","role":"aut","given":"Kathrin","display":"Schuster, Kathrin"},{"family":"Wilson","role":"aut","given":"Roger","display":"Wilson, Roger"},{"family":"Pignatti","display":"Pignatti, Francesco","given":"Francesco","role":"aut"},{"family":"Kasper","display":"Kasper, Bernd","given":"Bernd","role":"aut"}],"name":{"displayForm":["Silvia Stacchiotti, Gauthier Bouche, Ralf Herold, Pan Pantziarka, Kathrin Schuster, Roger Wilson, Francesco Pignatti, Bernd Kasper"]},"language":["eng"],"title":[{"subtitle":" The case of alveolar soft-part sarcoma","title":"How to develop new systemic treatments in ultra-rare cancers with high unmet needs?","title_sort":"How to develop new systemic treatments in ultra-rare cancers with high unmet needs?"}]} | ||
| SRT | |a STACCHIOTTHOWTODEVEL2024 | ||